PUBLISHER: The Business Research Company | PRODUCT CODE: 2035988
PUBLISHER: The Business Research Company | PRODUCT CODE: 2035988
Long oligo pool synthesis for capture is a method that generates a large collection of custom long oligonucleotides simultaneously. These oligonucleotides are specifically designed to bind with targeted nucleic acid sequences, enabling selective enrichment of specific regions of interest. Long oligo pool synthesis for capture enables high-throughput, accurate, and cost-efficient production of probes for downstream applications such as sequencing and molecular analysis.
The main product types of long oligo pool synthesis for capture include custom capture probe libraries, pre-designed capture panels, capture reagent kits, amplification and enrichment reagents, and design software and analytical tools. Custom capture probe libraries are sets of synthetic oligonucleotides specifically designed to selectively capture targeted genomic regions for downstream sequencing or analytical applications. The synthesis methods include array-based synthesis, column-based synthesis, microfluidic synthesis, and other synthesis methods. These products are applied in targeted sequencing, gene synthesis, clustered regularly interspaced short palindromic repeats (CRISPR) screening, synthetic biology, and other applications, serving end users including academic and research institutes, biotechnology and pharmaceutical companies, clinical laboratories, and other end users.
Tariffs on imported synthesis reagents, specialty nucleotides, microarray chips, and precision laboratory equipment have influenced the long oligo pool synthesis for capture market by increasing raw material and production costs. Custom capture probe libraries and reagent kits are most affected, particularly in North America and Europe that rely on Asia-Pacific supply chains for synthesis components. Higher costs may impact smaller research laboratories; however, tariffs are also encouraging domestic manufacturing of oligonucleotides, strengthening regional biotech supply chains, and promoting innovation in cost-efficient synthesis technologies.
The long oligo pool synthesis for capture market research report is one of a series of new reports from The Business Research Company that provides long oligo pool synthesis for capture market statistics, including long oligo pool synthesis for capture industry global market size, regional shares, competitors with a long oligo pool synthesis for capture market share, detailed long oligo pool synthesis for capture market segments, market trends and opportunities, and any further data you may need to thrive in the long oligo pool synthesis for capture industry. This long oligo pool synthesis for capture market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The long oligo pool synthesis for capture market size has grown rapidly in recent years. It will grow from $1.73 billion in 2025 to $1.97 billion in 2026 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to growth in next generation sequencing adoption, rising demand for targeted sequencing solutions, expansion of cancer genomics research, increasing use of gene panel testing, advancements in array based synthesis technologies.
The long oligo pool synthesis for capture market size is expected to see rapid growth in the next few years. It will grow to $3.31 billion in 2030 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to increasing demand for precision oncology applications, rising integration of ai driven probe design tools, growing investment in synthetic biology research, expansion of clinical genomic diagnostics, increasing need for scalable and multiplexed enrichment methods. Major trends in the forecast period include increasing adoption of high-plex target enrichment panels, growing demand for custom capture probe libraries, rising integration of automated probe design platforms, expansion of crispr screening applications, increasing focus on cost-effective high-throughput oligo synthesis.
The growing demand for precision medicine approaches is expected to drive the growth of long oligo pool synthesis for the capture market in the coming years. Precision medicine approaches are healthcare strategies that customize the prevention, diagnosis, and treatment of diseases according to the individual characteristics of each patient. The demand for precision medicine approaches is increasing due to the expanding adoption of genomic sequencing, which supports the development of personalized and more effective treatment options. Long oligo pool synthesis for capture supports precision medicine by enabling highly accurate genomic enrichment and probe design, which are critical for targeted sequencing, biomarker identification, and patient stratification in both clinical and research environments. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the U.S. Food and Drug Administration (FDA) approved 16 new personalized treatments for patients with rare diseases, representing a substantial increase from six approvals in 2022. Among these newly approved treatments, seven are oncology drugs, while three target other diseases and medical conditions. Therefore, the growing demand for precision medicine approaches is driving the growth of long oligo pool synthesis for the capture market.
Key companies operating in the long oligo pool synthesis for the capture market are focusing on adopting strategic partnerships to accelerate the development of high-complexity custom oligo libraries for advanced genomic applications. Strategic partnerships are structured alliances between organizations that leverage complementary strengths, expertise, and market access to strengthen competitive advantage and support long-term, sustainable growth. For example, in January 2023, Twist Bioscience Corporation, a US-based biotechnology company, partnered with Centogene N.V., a Germany-based diagnosis and research company focused on rare diseases, to launch three next-generation sequencing (NGS) target enrichment panels to advance rare disease and hereditary cancer research and diagnostics. The panels include the Twist Alliance CNTG Exome Panel (for whole exome rare disease analysis), the CNTG Rare Disease Panel (covering >2,500 genes for disorders such as treatable rare diseases and metabolic issues), and the CNTG Hereditary Oncology Panel (72 genes for cancer predisposition biomarkers). They are curated from CENTOGENE's Biodatabank of nearly 700,000 diverse patients and synthesized by Twist for precise variant detection.
The rising prevalence of genetic disorders is expected to drive the growth of long oligo pool synthesis for the capture market in the coming years. Genetic disorders are medical conditions caused by alterations or mutations in an individual's DNA that can impact overall health and development. The prevalence of genetic disorders is increasing due to improvements in medical diagnostics and genetic screening technologies, which enable more cases to be identified and accurately diagnosed compared to earlier periods. Long oligo pool synthesis for capture facilitates the accurate targeting and enrichment of specific genetic regions, enabling researchers and healthcare professionals to efficiently detect mutations and genetic variations responsible for genetic disorders, thereby supporting precise diagnosis, personalized treatment approaches, and the development of targeted therapeutic solutions. For instance, in October 2024, according to the Cystic Fibrosis Trust, a UK-based national charity, 11,148 individuals were living with cystic fibrosis (CF) in the UK in 2022, which increased to 11,318 in 2023. Therefore, the rising prevalence of genetic disorders is driving the growth of long oligo pool synthesis for the capture market.
Major companies operating in the long oligo pool synthesis for capture market are Eurofins Genomics GmbH, Agilent Technologies Inc, BGI Genomics, GenScript Biotech Corporation, Twist Bioscience Corporation, Azenta Inc, DNA Script SAS, Synbio Technologies Inc, LGC Biosearch Technologies Inc, Bioneer Corporation, Gene Universal Inc, Ansa Biotechnologies Inc, Microsynth AG, Daicel Arbor Biosciences, iGeneTech Bioscience Co Ltd, Moligo Technologies AB, Creative Biogene LLC, SBS Genetech Co Ltd, MaxPrecision Labs Inc, Integrated DNA Technologies, Dynegene.
North America was the largest region in the long oligo pool synthesis for capture market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the long oligo pool synthesis for capture market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the long oligo pool synthesis for capture market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The long oligo pool synthesis for the capture market consists of revenues earned by entities by providing services such as barcode and index oligo pool generation for multiplexed NGS workflows and optimization and quality control (QC) services, including NGS-based validation of oligo pool uniformity and fidelity. The market value includes the value of related goods sold by the service provider or included within the service offering. The long oligo pool synthesis for the capture market also includes sales of automated parallel oligonucleotide synthesizers, precision liquid handling and microfluidic dispensing systems, and integrated oligo pool amplification and enrichment instrumentation. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Long Oligo Pool Synthesis for Capture Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses long oligo pool synthesis for capture market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for long oligo pool synthesis for capture ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The long oligo pool synthesis for capture market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.